摘要
背景与目的:肿瘤坏死因子相关凋亡诱导配体(TRAIL)是一种理想的抗肿瘤药物,但许多肿瘤细胞常对TRAIL诱导凋亡耐受。本研究探讨了喷他脒增强白血病K562细胞对TRAIL诱导凋亡敏感性。方法:利用光镜形态学和AnnexinVFITC/PI双标记凋亡细胞的流式细胞仪(FACS)测定两种方法观察喷他脒预处理K562细胞并继用TRAIL后凋亡的发生。应用蛋白印迹方法观察此过程中半胱氨酸-天冬氨酸蛋白酶(Caspase)-3,-8和聚ADP核糖聚合酶(PARP)等3种蛋白的蛋白剪切与X连锁凋亡抑制蛋白(XIAP)蛋白表达的改变。结果:在10μg/ml喷他脒作用K562细胞20h,K562细胞未发生凋亡,继用200ng/mlTRAIL作用4h后,光镜和AnnexinVFITC/PI双标记流式细胞仪方法均观察到细胞发生明显凋亡,并出现了Caspase-3,-8和PARP蛋白剪切,两者单独作用则无明显细胞凋亡发生。另外,喷他脒明显降低了XIAP表达。结论:喷他脒联合TRAIL可能成为肿瘤治疗的一种新策略。
Background and purpose: Tumor necrosis factor-related apoptosis inducing ligand (TRA1L) is a success- ful clinical anti-tumor agent, ttowever, not all tumor cells are sensitive to TRAIL-mediated apoptosis. In this study, we examined the TRAIL-induced apoptosis after pretreatment with pentanddine in K562 cells. Methods: When K562 ceils were pretreated with pentamidine followed by TRAIL, apoptosis of fells was analyzed by cellular morphology via viewing live ceils under a light micrnscope and annexin V-FlTC/propidium iodine FACS. Western blot was perfbrmed t. examine the cleavage of caspase-3,-8 and poly(ADP-ribose) polymerase (PARR) attd protein levels of X-linked inhibitor of apoptosis protein ( XIAP). Results: Apoptotic cell death occurred and cleavage of caspase-3, -8 and PARR appeared when K562 cells were pretreated with 10μg/ml of pentamidine followed hy 200 ng/rnl of TRAIL, In addition, penlamidine decreased protein levels of X1AP. Conclusions: Combined treatment with penlamidine and TRAIL may become a new slrategy for cancer lherapy
出处
《中国癌症杂志》
CAS
CSCD
2007年第12期951-954,共4页
China Oncology